RemeGen to close IPO early, JW Therapeutics prices
Chinese biopharmaceutical firm RemeGen will close the international orderbook for its Hong Kong IPO early as the deal is already many times covered, according to a source close to the listing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: